At close: December 13 at 4:00:02 PM EST
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Jan 1970) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 2 | -- | 2 | 2 |
| Avg. Estimate | 0.06 | 0 | 0.25 | 0.36 |
| Low Estimate | 0.05 | 0 | 0.25 | 0.26 |
| High Estimate | 0.07 | 0 | 0.26 | 0.46 |
| Year Ago EPS | 0.09 | -- | 0.15 | 0.25 |
Revenue Estimate
| Currency in ILS | Current Qtr. (Dec 2024) | Next Qtr. (Jan 1970) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 3 | -- | 3 | 3 |
| Avg. Estimate | 149.87M | -- | 602.31M | 644.28M |
| Low Estimate | 148.51M | -- | 594.03M | 636.67M |
| High Estimate | 150.71M | -- | 606.45M | 649.72M |
| Year Ago Sales | 130.6M | -- | 510.89M | 602.31M |
| Sales Growth (year/est) | 14.76% | -- | 17.89% | 6.97% |
Earnings History
| Currency in USD | 12/31/2023 | 3/31/2024 | 6/30/2024 | 9/30/2024 |
|---|---|---|---|---|
| EPS Est. | 0.06 | 0.07 | 0.05 | 0.07 |
| EPS Actual | 0.09 | 0.04 | 0.08 | 0.07 |
| Difference | 0.03 | -0.03 | 0.03 | 0 |
| Surprise % | 55.83% | -42.86% | 45.45% | 0.00% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Jan 1970) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0.06 | 0 | 0.25 | 0.36 |
| 7 Days Ago | 0.08 | 0 | 0.29 | 0.35 |
| 30 Days Ago | 0.08 | 0 | 0.29 | 0.35 |
| 60 Days Ago | 0.08 | 0 | 0.29 | 0.35 |
| 90 Days Ago | 0.08 | 0 | 0.29 | 0.35 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Jan 1970) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | 1 |
| Up Last 30 Days | -- | -- | -- | 1 |
| Down Last 7 Days | -- | -- | 1 | -- |
| Down Last 30 Days | -- | -- | 1 | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| KMDA | -35.83% | -- | 66.88% | 41.18% |
| S&P 500 | 5.00% | 12.00% | 2.10% | 12.20% |
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Buy to Buy | 11/14/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 8/15/2024 |
| Initiated | Stifel: Buy | 7/3/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 5/9/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/7/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 11/14/2023 |
Related Tickers
LFCR Lifecore Biomedical, Inc.
7.61
+0.40%
ANIK Anika Therapeutics, Inc.
17.16
-0.98%
RDHL RedHill Biopharma Ltd.
7.44
+4.35%
INCR InterCure Ltd.
1.3171
+0.54%
AMRX Amneal Pharmaceuticals, Inc.
7.83
-1.14%
RDY Dr. Reddy's Laboratories Limited
14.46
+0.42%
TAK Takeda Pharmaceutical Company Limited
13.42
-0.22%
TEVA Teva Pharmaceutical Industries Limited
16.50
-1.84%
HLN Haleon plc
9.76
+0.31%
DVAX Dynavax Technologies Corporation
12.96
-0.23%